Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ephedra ban lawsuit

This article was originally published in The Tan Sheet

Executive Summary

FDA is facing a second lawsuit over the ephedra ban by the marketer of Thermalean weight-loss supplement, according to a complaint filed in Birmingham, Ala. federal court March 23. The National Institute for Clinical Weight Loss alleges the agency did not meet its burden of proof in finding ephedra supplements presented unreasonable risk and violated the Administrative Procedures Act. NICW was barred from making drug claims for Thermalean under a 2003 consent decree (1"The Tan Sheet" Oct. 13, 2003, p. 4)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS096660

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel